No financial specifics were discussed and Bob explicitly said that he doesn't want to start over-promising and possibly under-delivering because of the effect it can have on the stock. The CFO said that they will start issuing guidance when their business is more fully evolved at which time they will be able to make predictions with more certainty.
My take - MMRF is still a startup in a market that hasn't really taken off yet. They are surviving and growing while their competitors are foundering. When EMR fully emerges through both governmental and market actions, MMRF is positioning itself to be a major player. Plus, MMRF has valuable IP.
News 
Market Data 
Discover 
AI
